Here's why competitiveness in generic drug market is at Risk
CNBC's Meg Tirrell speaks with Chip Davis, Association for Accessible Medicines president, about generic drugs facing pricing pressures

In this video

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email

Here's why competitiveness in generic drug market is at risk: Industry expert

CNBC's Meg Tirrell speaks with Chip Davis, Association for Accessible Medicines president, about generic drugs facing pricing pressures.